Arcutis Biotherapeutics Inc (ARQT)
9.43
+0.17
(+1.84%)
USD |
NASDAQ |
Nov 18, 16:00
9.45
+0.02
(+0.21%)
After-Hours: 20:00
Arcutis Biotherapeutics Price: 9.43 for Nov. 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2024 | 9.27 | 9.46 | 8.90 | 9.43 | 1.960M |
| Nov 15, 2024 | 9.84 | 10.04 | 9.11 | 9.26 | 3.019M |
| Nov 14, 2024 | 10.41 | 10.59 | 9.90 | 9.93 | 2.171M |
| Nov 13, 2024 | 10.33 | 10.76 | 10.04 | 10.47 | 2.28M |
| Nov 12, 2024 | 10.60 | 10.74 | 10.20 | 10.25 | 1.724M |
| Nov 11, 2024 | 10.97 | 11.02 | 10.74 | 10.84 | 2.035M |
| Nov 08, 2024 | 10.47 | 11.44 | 10.35 | 10.82 | 4.257M |
| Nov 07, 2024 | 10.30 | 10.78 | 9.895 | 10.40 | 5.357M |
| Nov 06, 2024 | 9.37 | 9.90 | 9.07 | 9.66 | 4.355M |
| Nov 05, 2024 | 8.59 | 9.33 | 8.45 | 9.30 | 2.584M |
| Nov 04, 2024 | 8.53 | 8.86 | 8.29 | 8.72 | 2.269M |
| Nov 01, 2024 | 8.45 | 9.105 | 8.45 | 8.67 | 2.055M |
| Oct 31, 2024 | 8.46 | 8.52 | 8.21 | 8.31 | 1.133M |
| Oct 30, 2024 | 8.48 | 8.86 | 8.48 | 8.52 | 905691.0 |
| Oct 29, 2024 | 8.70 | 8.76 | 8.32 | 8.56 | 1.854M |
| Oct 28, 2024 | 8.78 | 8.97 | 8.57 | 8.71 | 1.061M |
| Oct 25, 2024 | 8.39 | 8.88 | 8.37 | 8.75 | 1.797M |
| Oct 24, 2024 | 8.34 | 8.61 | 8.19 | 8.41 | 1.854M |
| Oct 23, 2024 | 8.32 | 8.50 | 8.11 | 8.35 | 2.009M |
| Oct 22, 2024 | 8.24 | 8.46 | 8.03 | 8.34 | 2.551M |
| Oct 21, 2024 | 8.75 | 8.81 | 8.272 | 8.31 | 2.310M |
| Oct 18, 2024 | 9.42 | 9.71 | 8.63 | 8.72 | 2.648M |
| Oct 17, 2024 | 9.73 | 9.79 | 9.44 | 9.49 | 945739.0 |
| Oct 16, 2024 | 9.37 | 9.81 | 9.33 | 9.72 | 1.093M |
| Oct 15, 2024 | 9.77 | 9.853 | 9.26 | 9.35 | 1.340M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.84
Minimum
Nov 30 2023
36.98
Maximum
Feb 08 2021
18.02
Average
18.50
Median
Mar 18 2020
Price Benchmarks
| Mirum Pharmaceuticals Inc | 41.42 |
| Biogen Inc | 157.94 |
| Vertex Pharmaceuticals Inc | 467.01 |
| NovaBay Pharmaceuticals Inc | 0.6998 |
| Palatin Technologies Inc | 0.95 |
Price Related Metrics
| PS Ratio | 7.744 |
| Price to Book Value | 7.046 |
| Earnings Yield | -18.98% |
| Market Cap | 1.104B |